PL13 Ethnic differences in cardiovascular risk factors and prevalence of diabetes mellitus: the Singapore experience

1998 ◽  
Vol 136 ◽  
pp. S27
Author(s):  
Chee Eng Tan

1999 ◽  
Vol 11 (1) ◽  
pp. 16-19 ◽  
Author(s):  
M Mafauzy ◽  
N Mokhtar ◽  
WB Wan Mohamad ◽  
M Musalmah

Two thousand five hundred and eight subjects from the state of Kelantan in North-East Peninsular Malaysia were included in this study to determine the prevalence of diabetes mellitus and impaired glucose tolerance and their association with cardiovascular risk factors. The overall prevalence of diabetes mellitus was 10.5% and impaired glucose tolerance was 16.5%. There was no difference in the prevalence of diabetes mellitus between males and females but the prevalence of impaired glucose tolerance was higher in females (19.0%) than in males (11.5%). Subjects with diabetes mellitus were more obese (38.4%) than normal subjects (24.1%). They also had a higher prevalence of hypertension (12.9%) and hypercholesterolaemia (71.9%) than normal subjects. Subjects with impaired glucose tolerance also had a higher prevalence of obesity (35.5%), hypertension (9.0%) and hypercholesterolaemia (63.0%) than normal subjects. In conclusion, the prevalence of diabetes mellitus and impaired glucose tolerance was high and they were associated with a high prevalence of obesity, hypertension and hypercholesterolaemia.



2001 ◽  
Vol 155 (1) ◽  
pp. 179-186 ◽  
Author(s):  
C.E Tan ◽  
S.C Emmanuel ◽  
B.Y Tan ◽  
E.S Tai ◽  
S.K Chew


1998 ◽  
Vol 15 (4) ◽  
pp. 334-338 ◽  
Author(s):  
J.T. Jimenez ◽  
M. Palacios ◽  
F. Cañete ◽  
L.A. Barriocanal ◽  
U. Medina ◽  
...  


Author(s):  
Antonio Ruiz-García ◽  
Ezequiel Arranz-Martínez ◽  
Juan Carlos García-Álvarez ◽  
María Eugenia García-Fernández ◽  
David Palacios-Martínez ◽  
...  


2007 ◽  
Vol 2 (04) ◽  
Author(s):  
P Akritopoulos ◽  
K Akritopoulou ◽  
E Fotiadis ◽  
S Patiakas ◽  
I Kontogiannis ◽  
...  


2020 ◽  
Vol 16 ◽  
Author(s):  
Ricardo Cohen ◽  
Noelia S Sforza ◽  
Romina G Clemente

Background: The association between obesity and a reduction in life expectancy is well established, and cardiovascular disease is a leading cause of mortality. Bariatric surgery has long been established as the most effective and durable intervention for obesity, and is the only intervention for obesity that consistently improves multiple comorbidities, reduces cardiovascular disease and long-term mortality. The purpose of this review article is to describe the impact of metabolic/bariatric surgery on type 2 diabetes mellitus and cardiometabolic parameters, including cardiovascular mortality. Methods: A systematic literature search of Pubmed, MEDLINE, and Cochrane Central Register was performed. We included randomized controlled trials, metanalysis, case-control trials, and cohort studies that contain data on reductions in cardiovascular risk factors and cardiovascular mortality in subjects who underwent metabolic/bariatric surgery from January 1, 2005, to June 1, 2020. Conclusion: There is sufficient evidence of randomized controlled trials that metabolic/bariatric surgery is associated with a significant improvement of all cardiovascular risk factors. Although studies are showing a reduction of macrovascular events and cardiovascular mortality, these findings come from observational studies and should be confirmed in randomized clinical trials.



Sign in / Sign up

Export Citation Format

Share Document